Citation Impact
Citing Papers
Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle
2008 Standout
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype
2007 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
2006 Standout
Synthetic Peptide Strategy for the Detection of and Discrimination among Highly Divergent Primate Lentiviruses
2001 StandoutNobel
Retroviral superinfection resistance
2005
Randomized Trial of Clinical Safety of Daily Oral Tenofovir Disoproxil Fumarate Among HIV-Uninfected Men Who Have Sex With Men in the United States
2013
High Diversity of HIV-1 Subtype F Strains in Central Africa
1999
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
2004 StandoutNature
The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activity
2011 StandoutNobel
HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges
2006
An Integrated Framework for the Inference of Viral Population History From Reconstructed Genealogies
2000
Enrollment Characteristics and Risk Behaviors of Injection Drug Users Participating in the Bangkok Tenofovir Study, Thailand
2011
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Advances and research directions in the prevention of mother-to-child HIV-1 transmission
2000
Updated US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis
2013
COVID-19: A promising cure for the global panic
2020 Standout
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Voluntary HIV counseling and testing acceptance, sexual risk behavior and HIV incidence in Rakai, Uganda
2005
Distinct efficacy of HIV-1 entry inhibitors to prevent cell-to-cell transfer of R5 and X4 viruses across a human placental trophoblast barrier in a reconstitution model in vitro
2008 StandoutNobel
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
HIV prevention among youth: A randomized controlled trial of voluntary counseling and testing for HIV and male condom distribution in rural Kenya
2019 StandoutNobel
Rapid testing strategies for HIV-1 serodiagnosis in high-prevalence African settings
2004
In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide
2010
HIV Postexposure Prophylaxis Use Among Ontario Female Adolescent Sexual Assault Victims: A Prospective Analysis
2008
Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV
2004
Bayesian Coalescent Inference of Past Population Dynamics from Molecular Sequences
2005 Standout
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
2010 StandoutNobel
Which Topical Microbicides for Blocking HIV-1 Transmission Will Work in the Real World?
2006
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
2009
Chemoprophylaxis with Tenofovir Disoproxil Fumarate Provided Partial Protection against Infection with Simian Human Immunodeficiency Virus in Macaques Given Multiple Virus Challenges
2006
The interaction of HIV with dendritic cells: outcomes and pathways
2007 StandoutNobel
Relaxed Phylogenetics and Dating with Confidence
2006 Standout
Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention
2012
Effects of chloroquine on viral infections: an old drug against today's diseases
2003 Standout
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Sexually transmitted diseases treatment guidelines
2003 Standout
Microbicides for HIV prevention: reality or hope?
2009
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
Bayesian Phylogeography Finds Its Roots
2009 Standout
Acute HIV revisited: new opportunities for treatment and prevention
2004
Occupational Exposure to HIV in Health Care Settings
2003
Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection
2015 StandoutNobel
The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines
2004
A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection
2007
Computational design of orthogonal nucleoside kinases
2010 StandoutNobel
Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV
2008
Postexposure Prophylaxis in Children and Adolescents for Nonoccupational Exposure to Human Immunodeficiency Virus
2003
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
The spread, treatment, and prevention of HIV-1: evolution of a global pandemic
2008
Evaluation of antiretrovirals in animal models of HIV infection
2009
Stimulus-responsive hydrogels: Theory, modern advances, and applications
2015
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
2013 Standout
Acyclic nucleoside phosphonates: Past, present and future
2006
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus–cell fusion
2005 Nature
Validating the vitality strategy for fighting drug resistance
2011 StandoutNobel
A dominant block to HIV-1 replication at reverse transcription in simian cells
2002
Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis
2005 Standout
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
2015 StandoutNobel
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
2009
Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice
2015 StandoutNobel
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
IL-10 Synergizes with Multiple Cytokines in Enhancing HIV Production in Cells of Monocytic Lineage
1995 StandoutNobel
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Unprecedented Degree of Human Immunodeficiency Virus Type 1 (HIV-1) Group M Genetic Diversity in the Democratic Republic of Congo Suggests that the HIV-1 Pandemic Originated in Central Africa
2000
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
Experimental and Clinical Pharmacology ofAndrographis paniculataand Its Major Bioactive Phytoconstituent Andrographolide
2013 Standout
Functional Hydrogels as Wound Dressing to Enhance Wound Healing
2021 Standout
Genital immunology and HIV susceptibility in young women
2012
Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings
2006 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Preexposure Prophylaxis for the Prevention of HIV Infection
2019
Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission
2011
Characterization of Human Antiviral Adaptive Immune Responses during Hepatotropic Virus Infection in HLA-Transgenic Human Immune System Mice
2013 StandoutNobel
Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men
2012
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1
2009
Post‐exposure prophylaxis for HIV infection in sexual assault victims
2019
Humanized mouse models of HIV infection.
2011
Works of Ron A. Otten being referenced
Direct stringency comparison of two macaque models (single‐high vs. repeat‐low) for mucosal HIV transmission using an identical anti‐HIV chemoprophylaxis intervention
2007
A molecular epidemiologic survey of HIV in Uganda
1998
Optimizing the Delivery of HIV Counseling and Testing Services: The Uganda Experience Using Rapid HIV Antibody Test Algorithms
1998
Differential replication and pathogenic effects of HIV-1 and HIV-2 in Macaca nemestrina
1994
Identification of a Window Period for Susceptibility to Dual Infection with Two Distinct Human Immunodeficiency Virus Type 2 Isolates in aMacaca nemestrina(Pig‐tailed Macaque) Model
1999
High Susceptibility to Repeated, Low-Dose, Vaginal SHIV Exposure Late in the Luteal Phase of the Menstrual Cycle of Pigtail Macaques
2011
Pig‐tailed Macaques Infected with Human Immunodeficiency Virus (HIV) Type 2GB122or Simian/HIV89.6pExpress Virus in Semen during Primary Infection: New Model for Genital Tract Shedding and Transmission
2001
Multiple Vaginal Exposures to Low Doses of R5 Simian‐Human Immunodeficiency Virus: Strategy to Study HIV Preclinical Interventions in Nonhuman Primates
2004
Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir
2008
Complete Protection from Repeated Vaginal Simian-Human Immunodeficiency Virus Exposures in Macaques by a Topical Gel Containing Tenofovir Alone or with Emtricitabine
2009
Efficacy of Postexposure Prophylaxis after Intravaginal Exposure of Pig-Tailed Macaques to a Human-Derived Retrovirus (Human Immunodeficiency Virus Type 2)
2000
Intermittent Prophylaxis with Oral Truvada Protects Macaques from Rectal SHIV Infection
2010